Estrogen receptor studies in carcinoma Breast is done on \ \ \ \ \ \ ? - Chitranjjan National Cancer Institute Kolkata - 2021

Chitranjjan National Cancer Institute Kolkata - 2021

Medical & Surgical Nursing

Easy

Appeared in: Chitranjjan National Cancer Institute Kolkata - 2021

Explanation

Estrogen receptors (ER) are proteins located in the nucleus of breast cancer cells, not freely circulating in the body.
To determine if a cancer is ER-positive, a physical sample of the tumor tissue is required for analysis.
The most common method for this analysis is Immunohistochemistry (IHC), which visually identifies the presence of these receptors in the tissue.
The test result is crucial as it determines whether the patient will benefit from hormone (endocrine) therapy, which blocks the effects of estrogen on the cancer cells.

Option A: Blood is not used for receptor status testing because the receptors are located within the tumor cells, not circulating in the bloodstream.
Option B: Urine is not used for analyzing breast cancer characteristics like receptor status.
Option D: The ovary is a primary source of estrogen production in premenopausal women, but the test for estrogen receptors is performed on the cancer tissue itself, not on the organ that produces the hormone.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Specimen for Estrogen Receptor (ER) testing in breast cancer as background academic context rather than a clinical decision trigger.
Determining the ER status of a breast tumor is one of the most critical predictive and prognostic factors in breast cancer management. It directly dictates the primary treatment strategy.
ER-positive tumors generally have a better prognosis than ER-negative tumors because effective targeted therapies are available.
Nursing care for patients on hormone therapy involves managing side effects like hot flashes, vaginal dryness, and an increased risk of blood clots or osteoporosis, depending on the specific drug.

How to Approach the Question

First, identify the core of the question: it asks for the specific material ('specimen') used for 'Estrogen receptor studies' in breast cancer.
Recall the basic biology of cancer receptors. Receptors are proteins that are part of the cell structure, in this case, the cancer cells.
Consider the options in this context: Blood and urine are fluids. While they can carry markers shed by tumors, they don't contain the intact tumor cells needed to analyze receptors on those cells.
The ovary produces estrogen but is not the site of the breast tumor itself. The test is about the tumor's characteristics, not the body's hormone source.
This leaves 'Tumor tissue' as the only logical option, as it is the only specimen that contains the actual cancer cells with their receptors.

Concept Tested & Keywords

QLyxG9yzOViTaL7NquE2lY

E6 Textbook of Biochemistry for medical StudentsDM Vasudevan Part 2 — Subpart B (pp 240-463 of 478) p. 114-116

E6 Pathology- ROBBINS & COTRAN PATHOLOGIC BASIS OF DISEASE 10TH Ed p. 1050-1052